文献速递技术与安全泌尿生殖US

脓毒性休克患者超声引导下脱水治疗试验:一项先导性随机对照研究

Deresuscitation Informed by Ultrasound in Patients With Septic Shock Trial: A Pilot Randomized Controlled Study.
PubMed 文献 · J Ultrasound Med · 2026-03-10

本先导性随机对照可行性试验纳入19例脓毒性休克成人患者,12例(63%)随机分入静脉淤血超声(VExUS)指导的液体管理组。干预期间VExUS组液体平衡为-65 mL(IQR -1733至2016),常规治疗组为2608 mL(IQR -435至4460),p=0.21。急性肾损伤、呼吸衰竭、住院死亡及30天死亡率两组无显著差异,但VExUS组发生率较低。结论认为VExUS指导的液体管理可行,未增加不良事件风险,可能减少液体输注量。

要点

  • VExUS可用于床旁识别静脉淤血和终末器官淤血,以个体化调整脓毒性休克患者的复苏与脱水治疗。
  • 本先导试验中VExUS指导组干预期液体平衡为-65 mL,常规治疗组为2608 mL,组间差异未达统计学显著(p=0.21)。
  • 急性肾损伤、呼吸衰竭、住院死亡及30天死亡率两组无显著差异,但VExUS组发生率较低。

核心结论

  • VExUS指导的脓毒性休克液体管理是可行的,未增加不良事件风险,可能减少液体输注量;但液体平衡组间差异未达统计学显著(p=0.21)。

研究设计与样本

  • 先导性随机对照可行性试验,纳入19例脓毒性休克成人患者,12例(63%)随机分入VExUS指导组,其余分入常规治疗组;所有参与者每日行超声检查,VExUS组将结果及液体管理建议告知临床治疗团队作为干预。

临床应用与阅片要点

  • 原文指出VExUS可在床旁用于识别静脉淤血和终末器官淤血,以个体化调整脓毒性休克患者的复苏与脱水治疗。
  • 本试验中VExUS组临床治疗团队获知VExUS结果及液体管理建议,但原文未给出具体VExUS分级阈值或液体管理方案细节。

局限性

  • 本试验为先导性可行性试验,样本量小(共19例,VExUS组12例)。
  • 液体平衡组间差异未达统计学显著(p=0.21)。
  • 原文结论指出可能减少液体输注量,语气为「可能」。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The venous excess ultrasound (VExUS) can be used at the point-of-care to identify venous overload and end-organ congestion in an effort to individually tailor resuscitation and deresuscitation in patients with septic shock.

METHODS: We conducted a pilot randomized controlled feasibility trial of VExUS-guided fluid management in adult patients with septic shock. Participants were randomized to VExUS-guided fluid management or usual care. Daily ultrasounds were performed on all participants; in the VExUS-guided study arm, the clinical care team was informed of the VExUS results and given a fluid management recommendation (the intervention).

RESULTS: We enrolled 19 participants; 12 (63%) were randomized to the VExUS arm. The intervention period fluid balance was -65 mL (interquartile range [IQR] -1733 to 2016) in the VExUS arm compared to 2608 mL (IQR -435 to 4460) in the usual care arm (p = .21). The secondary outcomes of acute kidney injury, respiratory failure, hospital, and 30-day mortality did not differ significantly between the 2 arms; although the rates were lower in the VExUS arm.

CONCLUSIONS: We demonstrate that VExUS-guided fluid management in patients with septic shock is feasible, was not associated with an increased risk of adverse events, and may reduce the volume of fluids administered.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Innes B, Allison C, Seidler N, et al. Deresuscitation Informed by Ultrasound in Patients With Septic Shock Trial: A Pilot Randomized Controlled Study. J Ultrasound Med. 2026. PMID: 41804824. doi:10.1002/jum.70219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。